A recent report indicated that the frequency of somatic mutations in cancer is associated with overall gene expression, with premature terminating mutations in TP53, ARID1, and NSD1, particularly those with high allele frequencies, playing a significant role in cancer development [32]. This evidence concerns the gene TP53 and cancer.